BRD2 and polycystic ovary syndrome: In our study, as much as 52.4% (33/63) of the PCOS patients showed elevated 17‐OHP and had been excluded for NCAH by means such as ACTH‐stimulation, LH/FSH ratio, and other discrimination criteria.41